Desmetramadol

From WikiMD's WELLNESSPEDIA

Desmetramadol (also known as O-Desmethyltramadol, O-DSMT, or 1-(3-methoxyphenyl)cyclohexanol) is an opioid analgesic and the main active metabolite of tramadol. It is significantly more potent than its parent compound, making it a key player in tramadol's analgesia.

Pharmacology[edit]

Desmetramadol is a mu-opioid receptor agonist, meaning it binds to and activates these receptors in the brain to produce its analgesic effects. It is also a weak norepinephrine and serotonin reuptake inhibitor, which may contribute to its analgesic and mood-altering effects.

Metabolism[edit]

Desmetramadol is formed from tramadol in the liver via the cytochrome P450 enzyme system, specifically the CYP2D6 enzyme. This process, known as O-demethylation, removes a methyl group from tramadol, transforming it into desmetramadol.

Clinical Use[edit]

Desmetramadol is not typically used directly in clinical practice, but its formation in the body is crucial for the effectiveness of tramadol. Some individuals, known as "poor metabolizers," have a less active form of the CYP2D6 enzyme and may not experience the full analgesic effects of tramadol due to reduced formation of desmetramadol.

Side Effects[edit]

As an opioid, desmetramadol can cause a range of side effects, including nausea, vomiting, constipation, drowsiness, and respiratory depression. It also carries a risk of dependence and withdrawal if used for extended periods.

See Also[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.